Refine by
In Vitro Study Suppliers Serving Namibia
43 companies found
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide ...
based inCorona, CALIFORNIA (USA)
For over 20 years, United Endoscopy has been a leader in providing state-of-the-art refurbished medical equipment and advanced equipment repair to its customers worldwide. Since its founding in 1996 by Jeremy Cooper, United Endoscopy has ...
based inMilpitas, CALIFORNIA (USA)
BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other ...
based inPipersville, PENNSYLVANIA (USA)
LAMPIRE specializes in custom polyclonal & monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues & organs, normal & disease state human serums & plasmas, cell media, OMNI C3 cell culture bags & contract ...
LAMPIRE's high-tech vivarium and staff are available for your lab animal projects. The expanded capacity and enhanced facilities can accommodate drug metabolism and pharmacokinetic (DMPK) studies, teratogenicity studies, small- and large-scale ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Scientific advisory meeting held with MHRA confirming the need of a Phase 3 study to support the improved skin permeation including potential superior efficacy claims. Exploring the feasibility of a clinical study to satisfy the Phase 3 requirements ...
based inBuffalo, NEW YORK (USA)
We are a medical technology company focused on changing outcomes for patients. We intend to cure all patients with implant biofilm infections by advancing technologies, enhancing the effectiveness of treatments, working alongside the existing ...
Currently under investigation to study the elimination of biofilm infections on prosthetic knee implants during early intervention procedures while maintaining the current standard of ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a ...
based inHanden, SWEDEN
BioThema developes, produces and sells reagents and kits for measuring ATP by the firefly luciferase reaction. Applications include rapid cell counting, cell proliferation and cytotoxicity, immunoassays, monitoring enzymes and metabolites, reporter ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inBrea, CALIFORNIA (USA)
NuLiv Science is a growing team of scientists, innovators, and creatives focused on developing and communicating the power of our patented ingredients. From humble beginnings starting in 1997, NuLiv Science has grown into a full range ingredient ...
InnoSlim® is a pharmaceutical-grade glucose and lipid metabolic regulator through activation of the adiponectin and AMPK signaling ...
based inLargo, FLORIDA (USA)
CONMED is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical ...
With strong fixation, less bone removal and a simple, self-punching technique, the Y-Knot® RC helps overcome the trade-offs of other rotator cuff fixation methods. The first self-punching all-suture anchor available, Y-Knot® RC anchors can ...
based inParamus, NEW JERSEY (USA)
Regenity Biosciences is a trusted partner in regenerative medicine. Founded in 1997, Regenity is a trailblazer in soft and hard tissue regeneration. We bring curiosity, scientific rigor, and a sense of urgency to creating transformative medical and ...
A sponge-like onlay with a leak resistant top layer that provides effective protection against CSF leakage. When hydrated, this highly drapeable matrix is easily repositionable and conforms to the complex surfaces of the brain or spinal cord. The ...
based inAlbano Laziale (RM), ITALY
Founded in 1980, with global headquarters in Rome (Italy), COSMED is a privately owned company manufacturing Cardio Pulmonary, Metabolic and Body Composition diagnostic equipment. Since its foundation, COSMED's primary goal has always been to ...
Q-NRG is the first Indirect Calorimeter specifically intended for Resting Energy Expenditure (REE) measurement on spontaneously breathing subjects. Indirect calorimetry provides an individual and dynamic metabolic assessment based on the actual ...
based inLa Rochelle, FRANCE
We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box ...
StarSurf® is a surface treatment process enabling to create a rough structure on the surface of implants made of titanium and titanium alloys thus improving their biological performance of osseointegration. Implants surface finishing plays a ...
based inBudapest, HUNGARY
CycloLab is a worldwide recognized and all-around cyclodextrin research and development company, having the longest tradition and broadest circle of customers. Since 1972, a staff of internationally acknowledged experts have been working in the ...
Incorporating new APIs into final products might prove challenging: stability, solubility, bioavailability, etc. issues may arise. Several attributes of these substances can be favorably altered by cyclodextrins. Cyclodextrins themselves can also ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PMC-402 is a monoclonal antibody that targets the human TIE2 that regulated activation, proliferation, and repolarization of Tie2 expressing macrophages, resulting in T cell activation. It binds to TIE2 expressing macrophages that activate T cells ...
based inLa Verpillière, FRANCE
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint ...
Off-the-shelf devices available for key identified nasal drugs. Accelerate your sprint to market with our Device Equivalence Program. Based on FDA requirements, we have established a Device Equivalence Program in order to accelerate ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional antibiotics. ...
based inAlachua, FLORIDA (USA)
RTI Surgical (RTI) is a global, industry leading surgical implant supplier that provides design, new product development, processing and manufacturing services in support of patients and leading medical technology companies. With expertise in tissue ...
RTI Surgical offers the only meniscal allograft with both bone and meniscus sterilized through the BioCleanse® Tissue Sterilization Process. The BioCleanse processed meniscus graft provides a sterilized alternative to traditional aseptically ...